Fang Ziwen, He Jianxing, Fang Wanqiang, Ruan Lingling, Fang Fang
Southern Medical University Kaiping Central Hospital, Southern Medical University affiliated NanFang Hospital Thoracic Surgery Department Guangzhou, Guangdong China.
Southern Medical University Kaiping Central Hospital, Southern Medical University affiliated NanFang Hospital Thoracic Surgery Department Guangzhou, Guangdong China.
Heart Lung Circ. 2016 Apr;25(4):392-7. doi: 10.1016/j.hlc.2015.08.022. Epub 2015 Oct 8.
To evaluate the efficacy and long-term survival outcomes of complete video-assisted thoracoscopic surgery (C-VATS) for the resection of anatomic pulmonary segments and systematic lymphadenectomy in the treatment of elderly and high-risk patients with stage IB for non-small cell lung cancer (NSCLC).
242 elderly patients (≥65 years), who were operated on by the same operational team, were divided into high-risk group and conventional risk group from August 2008 to December 2010. All patients were diagnosed in stage IB (pT status: >2 to ≤3) NSCLC by biopsy and examination of PET-CT before operation. The high-risk patients were identified with severe cardiopulmonary and other system dysfunctions as follow-up criteria. They were treated with VATS anatomic pulmonary segments and systematic lymphadenectomy. The conventional risk patients with adequate cardiopulmonary reserve were treated with VATS radical lobectomy and systematic lymphadenectomy. The clinical and pathological data were recorded. The total survival, tumour-free survival, recurrence time and character of patients were followed-up. Appropriate statistical analyses involved the χ(2) test and Kaplan-Meier estimates of total survival and tumour-free survival.
A total of 242 patients underwent surgical resection during our study period: Anatomic pulmonary segments in 116 patients and lobectomy in 126. The operative time and blood loss of the VATS anatomic pulmonary segments group (78.0±35.0 min, 95.6±30.4 ml) were significantly less than those of the VATS radical resection group (108.0±25.0 min, 165.6±58.4 ml). Neither group experienced post-operative death. The overall and tumour-free survival rate of the VATS anatomic pulmonary segments group within five years were 62.07% and 29.31%, and those of the VATS radical resection group were 63.49% and 33.33%,%; there was no significant difference (P>0.5). The recurrence rates of the VATS anatomic pulmonary segment group and VATS radical resection group were 13.79% and 12.70%; there was no significant difference (P>0.5).
Thorascopic segmentectomy under anaesthesia and systematic lymphadenectomy is safe and minimally invasive and effective to treat a selected group of patients with stage IB NSCLC.
评估全胸腔镜手术(C-VATS)切除解剖性肺段并系统性淋巴结清扫术在治疗老年及高危ⅠB期非小细胞肺癌(NSCLC)患者中的疗效及长期生存结果。
2008年8月至2010年12月,242例老年患者(≥65岁)由同一手术团队进行手术,根据风险分为高危组和常规风险组。所有患者术前经活检及PET-CT检查确诊为ⅠB期(pT状态:>2至≤3)NSCLC。高危患者以严重心肺及其他系统功能障碍为随访标准。他们接受VATS解剖性肺段切除及系统性淋巴结清扫术。心肺储备良好的常规风险患者接受VATS根治性肺叶切除及系统性淋巴结清扫术。记录临床和病理数据。对患者的总生存、无瘤生存、复发时间及特征进行随访。适当的统计分析包括χ(2)检验以及总生存和无瘤生存的Kaplan-Meier估计。
在我们的研究期间,共有242例患者接受了手术切除:116例行解剖性肺段切除,126例行肺叶切除。VATS解剖性肺段切除组的手术时间((78.0±35.0分钟))和失血量(95.6±30.4毫升)显著少于VATS根治性切除组(108.0±25.0分钟,165.6±58.4毫升)。两组均未发生术后死亡。VATS解剖性肺段切除组5年内的总生存率和无瘤生存率分别为62.07%和29.31%,VATS根治性切除组分别为63.49%和33.33%;差异无统计学意义(P>0.5)。VATS解剖性肺段切除组和VATS根治性切除组的复发率分别为13.79%和12.70%;差异无统计学意义(P>0.5)。
麻醉下胸腔镜肺段切除术及系统性淋巴结清扫术治疗特定的ⅠB期NSCLC患者安全、微创且有效。